Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination dietary supplement containing collagen, typically provided as hydrolyzed collagen peptides intended to supply amino acids used in connective tissue protein synthesis, together with turmeric, a botanical ingredient usually standardized in part to curcuminoids such as curcumin. This combination is commonly marketed for joint comfort, skin health, and general wellness rather than as a regulated pharmaceutical product. Its proposed biological effects are nonspecific and product-dependent: collagen serves as a nutritional protein substrate, while turmeric is used for broad anti-inflammatory and antioxidant nutraceutical purposes, with commonly discussed effects involving modulation of inflammatory signaling pathways such as nuclear factor kappa B and cyclooxygenase related activity, although exact composition, dose, bioavailability, and clinical evidence vary substantially across manufacturers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on collagen + turmeric.